Clinical Trials
30 trialsADARNAT
Hospital Universitari de Bellvitge
Shared Decision Making on Radiation Dose for Lung Malignancies
Vejle Hospital
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
SISTER
University Medical Center Groningen
EPoRN
Jiangxi Provincial Cancer Hospital
STOPOMP
Mucosa Innovations, S.L.
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Cancer Trials Ireland
BIChE-1
University Hospital, Angers
HYP-OP-RT
CHU de Quebec-Universite Laval
ACUPUNCTURE
Wake Forest University Health Sciences
BELGICA
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
BRAINS
The Netherlands Cancer Institute
CTRCT-pedia
Centre Hospitalier Universitaire de Liege
FUSION-02
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
RADPAINT-3
Oslo University Hospital
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
University of Rochester
SMART-P01/02
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
FUSION-01
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
UNC Lineberger Comprehensive Cancer Center
RadioPARP
Institut Curie
MLD-HN
Lund University
PCS-XI
CHU de Quebec-Universite Laval
HYPO-5
CHU de Quebec-Universite Laval
Feasibility of the Maastro Applicator in Rectal Cancer
Maastricht Radiation Oncology
CANCER-COG
Centre Francois Baclesse
Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
Shanghai Proton and Heavy Ion Center
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
Shanghai Proton and Heavy Ion Center
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
Shanghai Proton and Heavy Ion Center
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
Peking Union Medical College Hospital
Omitting CTV for Primary Tumor in LS-SCLC
Sun Yat-sen University